Looks like ZIVO informed on new director addition today.
Expanded the BoD by 1. New independent director.
>>>>>>>>>>>
On February 8, 2021, the board of directors of ZIVO Bioscience, Inc. (the “Board” and the “Company”, respectively) appointed Ms. Alison A. Cornell to serve as a member of the Board and to fill a vacancy following the Board’s resolution on the same date to increase its membership size from five (5) to six (6) members. Below is a description of the relevant business experience for Ms. Cornell:
Ms. Cornell (58) currently serves as the Executive Vice President & Chief Financial Officer of Compassion-First Pet Hospitals, and has held such office since July 2017. Previously, she served as Executive Vice President & Chief Financial Officer of International Flavors & Fragrances Inc. (NYSE: IFF, Euronext Paris: IFF) from July 2015 through October 2016, and before that, she served multiple roles at Covance, Inc. (NYSE: CVD) from 2004 through July 2015, including Corporate Senior Vice President & Chief Financial Officer.
<<<<<<<<<<<
Certainly has the executive level credentials for relevant public companies.
Compassion First was founded by John Payne... ZIVOs chairman in 2014 and they fund vet hospitals. Fancy that. Payne is quite wealthy himself and knows people. Have never understood why he has not brought investors into the stock.
Instead of expanding the BoD should have cut dead weight.
Assuming this move has a purpose. We shall see. All of ZIVOs BoD would be considered independent except Dahl. Maybe NASDAQ looking for more current executive level experience. Maybe not.
Amigo Mike
